Skip to main content

HEALTH

  • Q&A: Market advice from Down Under

    Originating from Australia, Swisse Wellness recently made a splash into the U.S. market with brand ambassador Nicole Kidman leading the way. DSN didn't land an interview with Kidman, who was up for two Golden Globes last month, so we got in touch with her Swisse Wellness boss Radek Sali — CEO of the company and 2012 GQ Australia businessman of the year — for some insights into the company's approach to the U.S. launch.

    DSN: What's the opportunity for supplements in the U.S. market?

  • Lozenge sales stay healthy this flu season

    Sore throats and dry coughs are more prevalent symptoms associated with the flu. With the severe 2012-2013 flu season to date, that means a healthy amount of lozenge sales. One of the bigger winners across the top 10 vendors is Reckitt Benckiser, which launched Cepacol Sensations this fall. The product line contains a lower amount of numbing medication than traditional Cepacol products, yet still provides either an instantly cooling, warming or refreshing sensation. Sales of all Reckitt Benckiser lozenges totaled $10.9 million, up 67.6%.

     

     

  • Community-based diabetes efforts should involve retail pharmacies

    The YMCA is offering a demonstration project to show that its YMCA Diabetes Prevention Program — part of the Centers for Disease Control and Prevention's broader National Diabetes Prevention Program — can lower the incidence of Type 2 diabetes and reduce medical costs incurred by Medicare.

  • Patients oppose OTC-to-Rx switches for pseudoephedrine drugs, survey finds

    WASHINGTON — Patients around the country "strongly" oppose laws that have been proposed to change popular OTC drugs to prescription-only, according to a new survey.

    The survey, conducted online by Harris Interactive on behalf of the Asthma and Allergy Foundation of America, polled 2,020 adults in January who had asthma, allergies, cold, cough or flu in the past 12 months and who had purchased OTC drugs for at least one condition during that time.

  • Matrixx Initiatives gives Zicam a makeover with design firm Beardwood&Co

    NEW YORK — Matrixx Initiatives partnered with design firm Beardwood&Co on the redesign of Zicam Cold Remedy, which was unveiled Wednesday. 

    “We helped define [the pre-cold] segment,” noted Julia Beardwood, Beardwood&Co principal. “But, to be successful, we had to help consumers quickly sort through this myriad of products in the cold aisle and understand what Zicam is and when to take it.” 

  • CDC: Effectiveness of flu vaccine in seniors only 9%

    ATLANTA — This year's triumvirate influenza vaccine was less effective in seniors as compared to the general population, according to the Centers for Disease Control and Prevention's "Morbidity and Mortality Weekly Report" published Friday. Overall effectiveness of the vaccine was 56%, similar to an earlier interim estimate of 62%. 

    The adjusted, age-stratified vaccine effectiveness point estimates were 58% for children, 46% for adults younger than 50, 50% for men and women between the ages of 50 years and 64 years and 9% for seniors. 

  • Rise-N-Shine highlights Wake Up on Time energy supplement

    SPARTA TOWNSHIP, N.J. — Rise-N-Shine recently highlighted its Wake Up on Time supplement formulated to help night owls transform into morning people. Taken right before bed, Wake Up on Time starts to work six to eight hours later by releasing energy supplements for an alert, refreshed feeling.

    “It's more than a vitamin; it's time in a bottle because, instead of hitting the snooze button over and over again, our product allows you bounce out of bed, ready to go,” Cathy Beggan, founder of Rise-N-Shine stated. 

  • Study: Smoking cessation and reduced tobacco intake compels 'non-quitters' to quit

    ROCHESTER, Minn. — Smokeless tobacco users who said they didn’t want to quit changed their minds or significantly cut back when given nicotine lozenges or tobacco-free snuff in a Mayo Clinic study.

    The findings are published in the February issue of Addictive Behaviors.

X
This ad will auto-close in 10 seconds